News
Aytu Biopharma
AYTU · NASDAQ
$2.01+$0.05 (+2.55%)TodayMarket closed ·
Prev close $1.96
Latest news
- Press releaseACCESS Newswire
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
- News
Earnings Scheduled For September 22, 2026
- News
Full Transcript: Aytu BioPharma Q3 2026 Earnings Call
- News
Aytu BioPharma Q3 EPS $(0.53) Misses $(0.51) Estimate, Sales $12.411M Beat $12.053M Estimate
- Press releaseACCESS Newswire
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
- News
Earnings Scheduled For May 13, 2026
- News
Full Transcript: Aytu BioPharma Q2 2026 Earnings Call
- News
Aytu BioPharma Q2 Earnings Report: What Investors Need to Know
- News
Aytu BioPharma Earnings Review: Q2 Summary
- News
Aytu BioPharma Q2 Earnings Summary & Key Takeaways
- Press releaseACCESS Newswire
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
- Press releaseACCESS Newswire
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
- News
Insights into Aytu BioPharma's Upcoming Earnings
- Press releaseACCESS Newswire
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseACCESS Newswire
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
- News
Earnings Outlook For Aytu BioPharma
- Press releaseACCESS Newswire
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
- Press releaseACCESS Newswire
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseACCESS Newswire
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results
- News
Aytu BioPharma's Earnings: A Preview
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.